| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |